Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.
<a href="https://news.google.com/rss/articles/CBMilgFBVV95cUxNM3lEakF0ZWQ2YUNPYUFZcC1OeVdOY3hoZk9GaGJXeUQwcFEtWFVhN1JydDFDRjFWTm5pT21hUE9idWwwckVleUgxdEVyTjl0LXBRYS1MMk4wbnZ3YjZMM3pHVGVyaUZsZGVYcENsRHZXVWhidWtRc2xlOF81T1hnTWt2eGROb0ZxQWN2aGRxWjFKNzhVYkE?oc=5" target="_blank">Caribou Biosciences Discontinues Development for Vispa-cel & CB-011 CAR-T Cell Therapy Programs</a>&nbsp;&nbsp;<font color="#6f6f6f">Pharmaceutical Executive</font>
Jonas Brothers postpone Birmingham concert over weather concerns
Guardians' Steven Kwan Could Shake Up Winter Outfield Market
3 Storylines I'm Focused On in Warriors Preseason Game vs. Kings
PICTURES: Steffi Graf & Daughter Jaz Feature In Andre Agassi’s ‘Photo Dump’ As Carlos Alcaraz & Karl-Anthony Towns Make Surprise Appearance
Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1TYkxOa2tvODlZSDFvS1NhTDV3MEJqZUV3U1Q1aGtXZW9rNTJ0cTM4aVAwa2Z3OWwxM1RtaF83MEFDSHdvLUdhclVUTXlTRTJLekxHVjFSQXNpaWlBSTBN?oc=5" target="_blank">A guide to CAR T cell therapies: development, current status and future prospects</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxPNVMybzVIQUNISHh0ek8zZHRNZ0Nnd1E4bU1HUGRBdV9KQlFaa2VaM0JMcTNnelZxV1FTWnlqSjVOUF9iX3J0TmlCeS01bGkyTHk5bnRka0VITkgxblU3R0wyTFlCSmptendyYkZERlRnX0pDSFNwVXVBZHozT2lrYjdySUM5MHFPdnNfaXhWQW1rdw?oc=5" target="_blank">CAR-T cell therapy for autoimmune diseases: current clinical trial landscape and the next wave of development</a>&nbsp;&nbsp;<font color="#6f6f6f">Frontiers</font>
<a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxPWXdaRjcyRW1ST1RKeFV2Qk53a3N6RDVqQmdTelB0WDU5M2dCVjRGR21VZlhpclJyV0Z4YmxRSHM1RmRmTlpEemJWOXFVc0xBajNodDFLNFE1OFFWZW5PZWNFYVhBSUNKXzBxQS01ZUhEUmt1VW1odG92THVvaTM5bldTdDNPZFNYaXRwaHJvU3VicU51UUpLeUZia1hSelJVZDJhem5pU1dfUHM?oc=5" target="_blank">How Mechanistic Modeling Advances CAR T-Cell Therapy Development</a>&nbsp;&nbsp;<font color="#6f6f6f">BioPharm International</font>
<a href="https://news.google.com/rss/articles/CBMiZ0FVX3lxTE9zQ29Pa1VsRG1XeHY0b1JLNnhJN0xBRXg3ZXN3ejNNUVFNTkl5dDM1T2gxRXV1WGZxck1YMlpHMl83cXJkcGdHcUxnbXMtWlNaeVhMTnI1azJzX21JWUdzQ3dNTVpQWnfSAWxBVV95cUxPdTZCX19iaXNfN0VtQnRSWXJ0cmlVbGhWSUxObXdrdW1MUENrZ2hscW43LVpIM0VQSFFuMUtXbmxBQzRxYWhUcFI3NWVIb1NQY0o4ck5LczljUWM3SDU2cThlRlRtczBNSlgwSWE?oc=5" target="_blank">Strategies for the Future of CAR-T Therapy Development in 2026 and Beyond</a>&nbsp;&nbsp;<font color="#6f6f6f">BioInformant</font>
<a href="https://news.google.com/rss/articles/CBMiwgFBVV95cUxNTVg5TnhRV3BnZENvQXRkV1NFQ2QzUW1NVERoblBOS29ReG1KZDFHRkdqV2hFdGR0TTlsNkVCV29WZkplSXF2U3ZBN09Fb01ObUhqNWVOZDFqUHNmQ2hiYXo1QmFkQXlpOGNFY2dqVW12RHlVUVNjeGR6MDF6VkxGaHE4MzNNejE4bnVLQmQ4NXM1NDhsZUNJQ2laUlhqM1Z2NXdJZDJoZ0pZeUlFWjRoYTZlR0U1QmpQMU95V0tqWHZVZw?oc=5" target="_blank">Novartis pauses CAR T studies due to 3 deaths; BMS follows suit after safety events</a>&nbsp;&nbsp;<font color="#6f6f6f">BioSpace</font>
<a href="https://news.google.com/rss/articles/CBMiyAFBVV95cUxPcTE0ZnlMcVJYNkxjYllKUkxUNWpmU3R5U2tmWVpWcW5HREJpUUV6VWQ2MzN1QW1MWG1UVkJscGYwMjhKaTlyMlk4YmppZXVkcjl0X0VPdjllNXpwTzhCVDk3UkxyemVjbHBaU1lmOEhsRjdIbFNyVmJUNWJvQUo0bUhheTZmTU9HSFNYUUZIRHBpUUFubDN3cmd4R3hpcGRhUk95UXVCSlBaQkZmRGxieVZIa2JidF9VaVlLVjhPMXJnTTRqNEhoMA?oc=5" target="_blank">Off-the-Shelf CAR T-Cell Therapy Granted Breakthrough Therapy Designation for Aggressive T-Cell Cancers</a>&nbsp;&nbsp;<font color="#6f6f6f">AJMC</font>
<a href="https://news.google.com/rss/articles/CBMi6AFBVV95cUxNNkF0VDNUTFVDaXAzSUtKT1pUbHZHRVRsRkpNVGZ1RGlwLWp6Z3h0MUhpVHVPZHVxd2ZsVDhNT3BXV0oxLWpXVmhGeDdJczVqTXcwMnlOdUxSSTQ4ZlR0bDZDUGVDRzBmcXhLS2FDNTVpdjNQcnBmal9IMUI1V0ROMUJIQlBDVjk1OWNnTlgzZm1ianluWTdvbk1URkFwTTJWSElLVy1GVDJ0Mm5aQXZPNzlDSDY4aDlvd2tnQ0tPTnptSWhDamt3c01hTFBoZ1c4X0ZCUWREempfdlkyVFBZVU5VUXA0U1RK?oc=5" target="_blank">CRBU Stock Crashes 35% Premarket — RBC Slashes Target By 90% After Caribou Scraps CAR-T Programs</a>&nbsp;&nbsp;<font color="#6f6f6f">TradingView</font>
<a href="https://news.google.com/rss/articles/CBMia0FVX3lxTFBmZENCVmxTOFhQZk1CS3N0cjlTY2xZM1NudzhtRE9FNlowS1lrM2NGMnY2WVItQVJTV1VlYld3YU5QTFRHMkZPNnM3b1p4bGUzSjgyRk1fdjFiX2E4Q042LUFoWlpVa3FDbVpR?oc=5" target="_blank">CAR‐T Cells: Current Status, Challenges, and Future Prospects - Adly - 2026 - MedComm</a>&nbsp;&nbsp;<font color="#6f6f6f">Wiley Online Library</font>
<a href="https://news.google.com/rss/articles/CBMisgFBVV95cUxPYjlqZVNIZWRIaTBUU2ViWHFxN1dyMkpaZnFQTXhqSDRCOTN5VGt4cnFpWkZwbGFZMHhJNDVDOVVQLW8yTkVIWklOZnU3c19GTUxGZUM0VHBETDZBdUhZWWk5eGZRV1Jfekcyb0FJVS1SWVJSOHJQZ2M3YmlxVkRRZFdVeDRrZmZoa1NyMGNnVEo5bWpwVlY2eHhkNktKdkg1S1U0YjJ3eGtuNFgyZUJIbkFR?oc=5" target="_blank">In Vivo CAR T: A New Route to Treating Autoimmune Disease</a>&nbsp;&nbsp;<font color="#6f6f6f">The Medicine Maker</font>
<a href="https://news.google.com/rss/articles/CBMi1wFBVV95cUxQeXRPVmMwcjZKU0pWWlFLTUpMdXE5cXFuS00zVW0zNVp4UUpGTUVMQWxqT0t4RHdnVzhPVHpoaFE5Tm1XeHdOLXg2VGY1ZjRIcmU3UzlPLUpCNW9pR0NvN3JnbjBuaG1Nd1BPWTBicEZKa2RfN1lNRzZOQngwM25HYVYyb194UGlHZDA2ODNuMUpZYXM1bnRWUVVZcUtBU1c2ekVGOS1tVlM2cEVUQmd1eE9YT1RQSkRyTHZxV09ZWGx3aTNIdXhJUGJVTS1sQVo0TTliRHVWNA?oc=5" target="_blank">Cincinnati Children’s Chosen to Prepare Novel CAR‑T Therapy for Further U.S. Clinical Development</a>&nbsp;&nbsp;<font color="#6f6f6f">Research Horizons</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE43WVRRMkY3elBIcnp0TUJpV01HNEpabVNXcDY0WldTN3NEbk1faDNmWDdCdHVBNGtkOHlveVJwMnJ3b0dURUVvWV9rLVBKUzhsOVpmVU5LQ2tBNTA5ZVpN?oc=5" target="_blank">CAR T cell therapy beyond cancer: current status, challenges and future prospects</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxQRXE2REpjc3dGXzVxZDZKUGRkcXRHUUFYZHBMV0VSSnNRUjZLdHVhYnBVR0sxYjB6N29ZRlYyRHZNOGgtT0hweFIxUTBmc0pBUjdRZUdpX3I2aFVZUWFNbm11VU54aGVyUlU4V19pWnBTbEJFSHBDS1B1RG5HTmhQM1I3MW9XTzNERm92Z0ZxQ1I5QmRwVTZqc0g2X2tjbVJFNjI5V1ExRVNvZw?oc=5" target="_blank">Automation and AI Will Drive Next-Gen CAR T Manufacturing</a>&nbsp;&nbsp;<font color="#6f6f6f">Genetic Engineering and Biotechnology News</font>
<a href="https://news.google.com/rss/articles/CBMi6wFBVV95cUxOYVE1WmZ6Q1JxWVNyb0tFMDhUWWNURXU3WDBFekJVUUt4eWxMeHdzZzcwVEVpaEtHbVEzXzFmUWNZX05VVEZ4Q29uUlI0ZnRJTERhdG81S3RsRXV0TEd6RWRjUVNWang1dDVhbkZPbVZucWFSQ0pNV0t5S3dIYjVrcE1jdEtyT25wRm5LN1ZjaWNRZW1kRmFoQkNBaldBNlNJMlc0TENCTmFpQmFSZ0pHWjRDMHJjV3FZcmxIb1hvdWpfbGRTM1NNY2p1SWJFRV9kSlcwal9va0ViOHBrS1dCQ0ZUSjY5VGdVU0lj?oc=5" target="_blank">Press Release Service: Wugen Selected for U.S. FDA Chemistry, Manufacturing, and Controls Development and Readiness Pilot Program to Support Manufacturing Readiness of Soficabtagene Geleucel</a>&nbsp;&nbsp;<font color="#6f6f6f">CRISPR Medicine News</font>
<a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxNTkdXMEFBTzR3ZzJYa1hTcmQ0SFdjaU5KNUZlYVkxN1FkamNNbGQwel9RZnExeWhZNGZ3dlBhMm5qSWFXV1JvdF96T2k0Wng5MF9sS2tmZGVOVGdqYXVfVG01UXI0N1dROXY1emxKMGd0OHJOb2UtRVVmNVlkTG5LWk9zbXIxX09tMkZkR1JRU2FWdWVhNGo4aXA5Ni0yU3ZobjRKbHhuc2pPZFpWZENB?oc=5" target="_blank">Organoid models: reshaping the paradigm for precision development and evaluation of CAR-T cell therapies</a>&nbsp;&nbsp;<font color="#6f6f6f">Frontiers</font>
<a href="https://news.google.com/rss/articles/CBMi0AFBVV95cUxNNng5YnpGN1BHZF9vTHFMSzRjOWo0NmtNWTFYZTVMS3V3RTNudlBNbDRtUlhGZlYwSkxjMDFzS3oyNE1jOWtvWkM5bEJEcEpHOGo1b3M1alZaV1hLTXVIbWNyaGhlNkNZZGVISUoxeVFrY3p5bDV4ZkUtcmdiNWpGemE4RFZFMEVBZ3NyU1dVUFRXT205WkRtWld0MHZIY0lqaUk5YjM5OEZjWjExX2phWnV2eTk5aGlhcjl2T3pnY180WDRJaFVPNXBOQlBwMlNz?oc=5" target="_blank">Opinion: CAR T for autoimmune disease benefits from oncology’s lessons—and will deliver its own</a>&nbsp;&nbsp;<font color="#6f6f6f">BioSpace</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1va3hMQWMzZnZrVmdqcy1IMzlPTm4tRnpKaUFoV04tOURsVHlaVXo0REpHLTd4U0YzUDF6Z1JQcnRUSno0VVdueElDOWhMc3c2MjhpeDJHajdYRlg0RVFJ?oc=5" target="_blank">Clinical landscape and development of universal CAR-T cell therapies</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBxa0MwWTVQaFEwTnBUWTR2NGpVd002ZGJURnVXNFJPeHhXeHFpeUVqWDFmM0FpeThrWUkxMGdPVnF3bGViVnR1bXlHTVFmc2FleEhJNmxCU2pvOXBudlhn?oc=5" target="_blank">Tisa-cel and axi-cel CAR structure influences the development of resistance to CD19-CAR-T therapy</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9nOTdZMThMaFptOW5yTDcwbFJwQzVDNDVWbTlYT1NpSVRxTGN0NzRjMGJ1ZFh3bkhuRU9EdzkyUGJGc0FGeDBVSVZOSFNzRUhsTXNIRjh3YVcwOXhRYTBz?oc=5" target="_blank">Advances and prospects in cell therapy for cancer: explorations from T cells to stem cells</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9sR05RUmx3UHVIYXRTT0JIZmpLU3h6SFc5SGJuYXVQWjBvSVNGNHdRSXM4Z1BRb2p1S1NjYlhzNGdqc3NmUTdTbnhydWQtR240SDdhRmZvS1dwWnZJSmVn?oc=5" target="_blank">Discovery to delivery: solving the scaling challenge in cell therapy</a>&nbsp;&nbsp;<font color="#6f6f6f">Nature</font>
<a href="https://news.google.com/rss/articles/CBMipgFBVV95cUxQdTJrWndkMld3UzRlbmhGWnJDTFJxYktrZWxHV0E3MTdZN0dnLUpRdzJvUzE3SV9VS3V4NXJMcldKYlNxMG1KMDNqYnpYYTdNamd3Z1MyYUNOSnJrenl4VHl4d0JmYlJuaVlMc2xRbklEQ3M3N2RZSm9hZ1hPQzN4WWJUNTdBYlk1bWEyTjFkN2lTOUtGWDdERkVmaEZhaVA1T25tV1Rn?oc=5" target="_blank">In Vivo CAR Engineering and the Next Phase of Cellular Immunotherapy</a>&nbsp;&nbsp;<font color="#6f6f6f">CancerNetwork</font>
<a href="https://news.google.com/rss/articles/CBMiwwFBVV95cUxPcTV4bWVwOG5Yd3drM2tsaDN2S0NlQ0s1QUJYU016Y3JoVHAyVlFsVUZwbmNLRlRrSGZWQ1ZMSWF3TkdOMV80QS11QkxiMlhZSnU3SExOb3pIV1ptUXBtYlZUTVBBQzJKUDBBS3JUaXpLS3pnWDRVUU84NTRRZFhUd2wzekhpOUtRSUNQQ1llT2dmNWRBRUpCQU5sMXQtUnYxUGE2NVFmaXRBU3FpMmYxN1RHU1hsMEJCbmNXN1JiSy00MWc?oc=5" target="_blank">Setting Specifications for CAR-T Therapy According to Program Development Phase</a>&nbsp;&nbsp;<font color="#6f6f6f">BioProcess International</font>
<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxQMTNtZUtpalpUTTVXMGxsXzB6Ni05ZzFwTVFtMGNhWjVEeVR1YlVUbGlybDlQbDRFeE95VWY0VkRMWmRKZ2ttamFSckFlNGp0ZFAzLVpsYmFhVEhjd2VkRnJaa0N1Zk50YmEtYWFsa05naWd3cjR1YkotTHl3aHpxaUx3ZkdnWHVLVmpEemFSTFpZb0ZPVGc4?oc=5" target="_blank">Spatial biology in cell and gene therapy development</a>&nbsp;&nbsp;<font color="#6f6f6f">Drug Discovery News</font>
<a href="https://news.google.com/rss/articles/CBMixgFBVV95cUxPMG8zWVVFcTlFcFhPWTNqTUV3cFBEMm91YkRnNTRXWkRYclRCWDJsOVM4ZDlaNVpwazJ2SjZRalFFTHViVmdIWUtGeWp6ejhQVXYwN1lucUtoUkVXb25TSWhNTXpiLVlHS3JsOEtreGdUZVBYaW5rczdXdDVWRmMyZ2phdEZEUnB1S0NCVmZiWHJ6MkdrTXl2dVBZb2FYajhGMExOaW12Q0d2UkpDTFNjclFnS0xUajR1VEdtdFhUTmRwMldoVEE?oc=5" target="_blank">CAR T Cell Therapy Biomanufactured by Cellares Infused Into First Two Patients</a>&nbsp;&nbsp;<font color="#6f6f6f">Genetic Engineering and Biotechnology News</font>
<a href="https://news.google.com/rss/articles/CBMiqAJBVV95cUxNUnNmNFBDajVhWmlkdkppTVVlTTFEMDhpc19BUVlPRzRwcDRaSWVDWTNJNGxGVW5GTHUteHp6cUhKRUVXRWVtVTNKQTBHam16TGZJY0hsS0FLUHpWZzJycnZQVUctRUFtNDloZjZhMXFIRElJckw2dTNNWWR1WHcxZG5KTHIxaGxkWUt3czQzb0Z0UUhVeXk5blhSOFhLUFhOcGd5TlFaQlJXaEp5VUZJdThjSXN0Y0h1M1RsSW1yNTlEVHlvRzN1dU1XaHJGcGEySkc0OVVLZnk4dGZGdFdHQmZCeUNpTUNLMkt1N0lFcDluNE9US1pydWI0Zm5pT2g3aVVTVlppRmdjdF9GaUlnbzBsSHNZODRLZjVKbmpkb1BjTHhGdjdqeg?oc=5" target="_blank">Tempest Announces Development Collaboration with Senlang Biotechnology for TPST-4003, a CD7-Targeted Next-Generation In Vivo CAR-T</a>&nbsp;&nbsp;<font color="#6f6f6f">GlobeNewswire</font>
<a href="https://news.google.com/rss/articles/CBMiakFVX3lxTE9Ub1E3bWM0YVF6TE15QnlLM0V0SllqbUFPZDJ2b0pnV0daYjJqbFJSdFFzQkkxUUlXZEVrVmt1ZjkxTnMxMjBzWG10b3U3a0ZIcWZ1UFlrMjlNTkprTE1JZlVNUDQ1Rk0xS0E?oc=5" target="_blank">Strategies of AI‐Driven CAR‐T Cell Therapy Towards Solid Tumours - Abdalla - 2026 - Immunology</a>&nbsp;&nbsp;<font color="#6f6f6f">Wiley Online Library</font>
<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxQb0V5R2h1amdlRWlQNGVFWmhxRVhIVndSVWxhNUVqWmJRUDlFMW1aOXJ6N2tQQldLS2xFTmxaVU15YlVfUHlwbFhUd3d3TENaVkpfSTA0aFRMT29icUVGTG9WellzTVU4ZnpjdnpNdkpSa2ctWGM2LWc3MzZ6T1dUdEp1a013VmRSTkpOOW1pVVBORGU4QjlvM2hBRk5tQQ?oc=5" target="_blank">Roche drops TCE for lupus, but hasn’t given up on autoimmune cell therapies</a>&nbsp;&nbsp;<font color="#6f6f6f">Fierce Biotech</font>
<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxNaElseHBUb2pQRFZCVm8xTFJIRlpvYUhNaFlCTHFFRWctRFlWUDBmcnZhcG5tak5rdHVIVnF4YmdRZlBXVXFmY0MxdFNwTmJVZHNoLUhkN1RVeDM3RkxfWmxxcFlrWmpqTGRaSjc3bWFzblN1OUNCQ01tSmxoX0w0Z2ItUWtLMkg2MHNOdHc1VEI0WTNYc3A3QldCVTRNT0IzQ0VQYVJIdmJpVDRnZTZBa2ZaczR2QQ?oc=5" target="_blank">Has Novartis’ T-Charge been overtaken by in vivo CAR-Ts? Execs argue there’s room for both</a>&nbsp;&nbsp;<font color="#6f6f6f">Fierce Biotech</font>
<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxPNEtTd0RvbV9NcEhLejNidnl6UFZVQV9TcHhjemNGZTU5LXdGeGg1Z25DT2E5Q1BvM2J3LWQ1T1lTaHZYaHVhZ2ppRXlvU1JoWVBKUmEydWh4N1pqOFhyRldLYkJiSUhQUzhOUGF3aVFfNDFPc1E0SWNpQ2UzR1BuOURzT3p3aXJmbWNhMUtjdVVQQWRTTXFr?oc=5" target="_blank">Germany CAR T-Cell Therapy Market Size, Share,Trends, Growth Analysis Report, 2031</a>&nbsp;&nbsp;<font color="#6f6f6f">MarketsandMarkets</font>
<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxPbHNMWDFqRDFGUVZZbTFnQjR5R0ZXaHBfaFgtbXNWdUp2MHVGSXBVV2FXbWEtWWpnT0E1ZXlCT1Z5MWVSa1hNUTFlMWd2Ry03X0I2akp5RzFMekM3SlJXRVVrN1QwTVVxX2VNNWJLanVXc1J2QXZMcVk1UlVrRy1yaThOcjV2ZmUxblpZd2t3?oc=5" target="_blank">Current positioning and future development of belantamab mafodotin and other antibody-drug conjugates to treat multiple myeloma</a>&nbsp;&nbsp;<font color="#6f6f6f">Frontiers</font>